Clinical trial

Olmesartan Medoxomil in Atherosclerosis

NCT00185185

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-11-01

PhasePHASE3

Study timeline

Study start (unknown)2001-11-01Date precision: month

Registry last updated2007-12-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Essential Hypertensionunresolved

Atherosclerotic Cardiovascular Diseaseunresolved

Interventions

Olmesartan medoxomilDRUG · verified · RxNorm: olmesartan medoxomil

AtenololDRUG · verified · RxNorm: atenolol

HydrochlorothiazideDRUG · verified · RxNorm: hydrochlorothiazide

olmesartan medoxomilDRUG · verified · RxNorm: olmesartan medoxomil

atenololDRUG · verified · RxNorm: atenolol

Sponsors & collaborators

Sankyo Pharma Gmbhlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00185185 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.